Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 263-580-6 | CAS number: 62518-65-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction: other studies
Administrative data
- Endpoint:
- toxicity to reproduction: other studies
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP, Draft guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Draft OECD Guideline for the Testing of Chemicals; The Hershberger Bioassay in Rats: A Short-term Screening Assay for (Anti)Androgenic Properties
- GLP compliance:
- yes (incl. QA statement)
- Type of method:
- in vivo
Test material
- Reference substance name:
- 3-(m-tert-butylphenyl)-2-methylpropionaldehyde
- EC Number:
- 263-580-6
- EC Name:
- 3-(m-tert-butylphenyl)-2-methylpropionaldehyde
- Cas Number:
- 62518-65-4
- Molecular formula:
- C14H20O
- IUPAC Name:
- 3-(3-tert-butylphenyl)-2-methylpropanal
- Details on test material:
- - Name of test material (as cited in study report): V4 m-Lysmeral Destillation Fr. 6
- Physical state: liquid/colorless, clear
- Analytical purity: 99.22 Area %
- Impurities (identity and concentrations):p-Lysmeral 55 mg/kg
- Storage condition of test material: ambient (room temperature); under Argon
The stability of the test substance in Olive Oil Ph. Eur. at room temperature for a period of 7
days was demonstrated.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories; Germany
- Age: 45 +1 days at castration, 52 +1 days at test substance administration
- Housing: 3 animals per cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: approx 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Analytical verification of doses or concentrations:
- yes
- Duration of treatment / exposure:
- 10 days
- Frequency of treatment:
- daily
- Duration of test:
- 10 days
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 50, 150, 450 mg/kg bw/d
Basis:
- No. of animals per sex per dose:
- 6
- Control animals:
- other: vehicle control without TP; vehicle control with TP; Flutamide control with TP
- Details on study design:
- EXPERIMENTAL PROCEDURE
On day -7 of the study all animals were castrated. The test substance was administered daily for 10 days. The Antagonist groups were treated
with Testosterone-Propionate (0.4 mg/kg bw/day) subcutaneously. Control animals received the vehicle, Testosterone-Propionate (TP) or Testosterone-Propionate+Flutamide (TP+FL). All animals were sacrificed after a fasting period (withdrawal of food) of at least 16 hours.
Mortality:
checked twice daily on working days and once daily on Saturdays, Sundays and public holidays. If animals were in a moribund state, they were sacrificed and necropsied.
Clinical observations:
checked daily before and after the administration for any clinically abnormal signs.
Food consumption:
determined on day 5 and 9, calculated as mean food consumption in grams per animal and day.
Water consumption:
observed daily by visual inspection of the water bottles for any overt changes in volume.
Body weight:
determined before the start of the administration period in order to randomize the animals; daily during the administration period.
Food efficiency
calculated based upon individual values for body weight and food consumption.
Necropsy:
Animals were sacrificed by decapitation under Isoflurane anesthesia. The exsanguinated animals were necropsied and assessed by gross pathology.
Organ weights:
fresh (unfixed) weights were determined in all animals after they were carefully trimmed of excess adhering tissue and fat. Each tissue was weighed without blotting (sex accessory tissues, kidneys and adrenal glands to the nearest 0.1 mg, liver and anesthetized animals to the nearest 0.1 g).
1. Anesthetized animals
2. Ventral prostate (VP)
3. Seminal vesicle together with coagulation gland (SVCG)
4. Musc. levator ani together with Musc. bulbocavernosus (LABC)
5. Bulbo-urethral gland (COW)
6. Adrenal glands
7. Glans penis (GP)
8. Liver
9. Kidneys
TEST GROUPS AND DOSES:
Negative control group:
0. vehicle control
1. vehicle control + testosteron propionate (0.4 mg/kg bw/d)
Positive control:
2. Flutamide (3 mg/kg bw/d) + testosteron propionate (0.4 mg/kg bw/d)
Antagonist groups:
3. m-Lysmeral (50 mg/kg bw/d) + testosteron propionate (0.4 mg/kg bw/d)
4. m-Lysmeral (150 mg/kg bw/d) + testosteron propionate (0.4 mg/kg bw/d)
5. m-Lysmeral (450 mg/kg bw/d) + testosteron propionate (0.4 mg/kg bw/d)
Agonist groups:
6. m-Lysmeral (50 mg/kg bw/d)
7. m-Lysmeral (150 mg/kg bw/d)
8. m-Lysmeral (450 mg/kg bw/d) - Statistics:
- Body weight, body weight change: DUNNETT's test (two-sided)
Weight parameters (VP, SVCG, LABC, COW, GP): DUNNETT’s test (one-sided) for TS treated groups; Student’s t-test (one-sided) for the neg/ pos control group comparison.
Weight parameters (terminal body weight, liver, kidney, adrenal gland): DUNNETT’s test (two-sided) for TS treated groups; Student’s t-test (two-sided) for the neg/ pos control group comparison.
Results and discussion
Effect levels
- Dose descriptor:
- NOAEL
- Remarks:
- anti-androgenic or androgenic
- Effect level:
- 450 mg/kg bw/day
- Sex:
- male
- Basis for effect level:
- other: no effects on reproductive organs observed
Observed effects
0. vehicle control
Clinical Examinations: No adverse findings
Pathology: No adverse findings
1. vehicle control + testosteron propionate (0.4 mg/kg bw/d)
Clinical Examinations: No adverse findings
Pathology:
Weights of adrenal glands significantly reduced compared to test group 0
Weights of seminal vesicle together with coagulation gland (SVCG), bulbo-urethral gland (COW), ventral prostate (VP), glans penis (GP) and muscles levbator ani together with bulbocavernosus (LABS) significantly increased compared to test group 0
No other substance related adverse findings
Positive control group:
2. Flutamide (3 mg/kg bw/d) + testosteron propionate (0.4 mg/kg bw/d)
Clinical Examinations: No adverse findings
Pathology:
Weights of seminal vesicle together with coagulation gland (SVCG), bulbo-urethral gland (COW), ventral prostate (VP), glans penis (GP) and muscles levbator ani together with bulbocavernosus (LABS) significantly reduced compared to test group 1
Antagonist groups:
3. m-Lysmeral (50 mg/kg bw/d) + testosteron propionate (0.4 mg/kg bw/d)
Clinical Examinations: No substance related adverse findings
Pathology (reproductive organs): No substance related adverse findings
4. m-Lysmeral (150 mg/kg bw/d) + testosteron propionate (0.4 mg/kg bw/d)
Clinical Examinations: No substance related adverse findings
Pathology (reproductive organs): No substance related adverse findings
Absolute/ relative weights of bulbo-urethral gland were significantly reduced compared to the controls. Finding is not considered as adverse or as hormonal (anti-androgenic) action, due to lack of dose-response relationship, negligible magnitude of effect compared to Flutamide treated controls and lack of significant alterations in other examined androgen-dependent organs/tissues in this group.
5. m-Lysmeral (450 mg/kg bw/d) + testosteron propionate (0.4 mg/kg bw/d)
Clinical Examinations: No substance related adverse findings
Pathology (reproductive organs): No substance related adverse findings
Agonist groups:
6. m-Lysmeral (50 mg/kg bw/d)
Clinical Examinations: No substance related adverse findings
Pathology (reproductive organs): No substance related adverse findings
7. m-Lysmeral (150 mg/kg bw/d)
Clinical Examinations: No substance related adverse findings
Pathology (reproductive organs): No substance related adverse findings
8. m-Lysmeral (450 mg/kg bw/d)
Clinical Examinations: No substance related adverse findings
Pathology (reproductive organs): No substance related adverse findings
Any other information on results incl. tables
Other statistically significant organ weight changes:
Kidney: increase of absolute/relative weights (vs ctrl):
test group 4 (150 mg/kg bw/day + TP): 117%/ 115%
test group 5 (450 mg/kg bw/day + TP): 116%/ 117%
test group 8 (450 mg/kg bw/day): 114%/ 116%
Liver: increase of absolute/relative weights (vs ctrl):
test group 4 (150 mg/kg bw/day + TP): 127%/ 125%
test group 5 (450 mg/kg bw/day + TP): 161%/ 162%
test group 7 (150 mg/kg bw/day): 118%/ 118%
test group 8 (450 mg/kg bw/day): 160%/ 163%
The weight increase of livers is a substance-related effect. A treatment-related increase of kidney weights seems unlikely, but no histomorphological investigation was carried out. The increase of liver weights is comparable to the repeated dose 28-day toxicity study in Wistar rats (BASF 2009; 30S0875/08053). Histomorphological examination in the 28- day toxicity study revealed a centrilobular hypertrophy of hepatocytes and it was regarded as an adaptive, detoxifying (cytochrome P450 enzyme induction) response to treatment. Since there is no histopathology in this study, no final assessment can be provided.
Gross lesions:
Enlargement of liver in all animals of test group 5 (450 mg/kg bw/day + TP) and test group 8 (450 mg/kg bw/day), being considered as substance related effect.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.